Item 4 is hereby amended and restated as follows: (a) - (c) On November 22, 2022, Fund and Fund II entered into a Loan and Security Agreement, and related agreements (collectively, the "Agreement"), by and among Issuer, as borrower, Fund and Fund II, as lenders, and Manager, as administrative agent and collateral agent, pursuant to which lenders agreed to fund an initial Growth Capital Loan (as defined in the Agreement) in the aggregate original principal amount of $10 million (the "Principal"). As consideration for the commitment, Reporting Persons received an equity grant equal to 547,807 shares of Issuer's common stock. Reporting Persons initially had the right to convert up to $5 million of the Principal into 2,327,746 shares of Issuer's common stock at a conversion price of $2.148. As of November 22, 2022, the Reporting Persons beneficially owned 2,875,553 shares, or 7.38%, of Issuer's common stock based on 36,112,987 shares of Issuer's common stock issued and outstanding as reported by the Issuer as of November 11, 2022. According to information received from the Issuer, as of June 30, 2024, there were 55,817,921 shares of Issuer's common stock issued and outstanding, and the Reporting Persons beneficially owned 4.9% of the Issuer's common stock. On November 22, 2024, pursuant to a First Amendment to the Supplement to the Agreement, Issuer issued Reporting Persons 1,907,733 shares of common stock. Such issuance resulted in the Reporting Persons beneficially owning 4,777,286 shares, or 5.24%, of the Issuer's common stock based on 86,441,661 shares of Issuer's common stock issued and outstanding as of November 8, 2024. According to information received from the Issuer, as of December 9, 2024, there were 111,425,129 shares of Issuer's common stock issued and outstanding, and the Reporting Persons beneficially owned 4.11% of the Issuer's common stock. Effective as of Issuer's one-for-eighty reverse stock split on January 31, 2025, Reporting Persons beneficially owned 2,358,365 shares, or 52.90%, of the Issuer's common stock based on 2,100,000 shares of Issuer's common stock issued and outstanding as reported by the Issuer as of January 28, 2025. On February 21, 2025, pursuant to a Second Amendment to the Supplement to the Agreement Reporting Persons acquired the right to convert, at any time on or after April 1, 2025, up to $10 million of the Principal at $1.68 per share, resulting in the Reporting Persons beneficially owning 5,983,000 shares, or 74.02%, of the Issuer's common stock based on 2,100,000 shares of Issuer's common stock issued and outstanding as reported by the Issuer as of January 28, 2025. According to information received from the Issuer, as of April 11, 2025, there were 2,830,546 shares of the Issuer's common stock issued and outstanding, and the Reporting Persons beneficially owned 67.88% of the Issuer's common stock. On May 30, 2025, Reporting Persons and the Issuer entered into a Third Amendment to the Supplement to provide a 9.99% "blocker" provision designed to prevent Reporting Persons from being beneficial owners of more than 9.99% of the Issuer's Common Stock. Other than entering into the Agreement and amendments described herein, Reporting Persons have not engaged in any transaction with respect to the shares of Issuer's common stock. The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the common stock in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as they may deem appropriate in light of the circumstances existing from time to time, which may include disposal of some or all of the shares of common stock currently owned by the Reporting Persons or otherwise acquired by them pursuant to conversion of debt or in privately negotiated transactions. Any such transactions may be effected at any time or from time to time subject to any applicable limitations imposed on the sale of the common stock by applicable law. Except to the extent the foregoing may be deemed a plan or proposal, the Reporting Persons have no additional plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of the Schedule 13D. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.